NRS announces 2007 research grants

Written by on January 16, 2007 in National Rosacea Society, research foundation, VEGF with 0 Comments

The National Rosacea Society have announced their latest round of rosacea grants. 5 new grants have been awarded, some as followup to previous grants.

  1. Dr. Cremers will investigate the levels of angiogenesis markers, such as vascular endothelial growth factor (VEGF), in the conjunctiva and eyelids of patients with severe ocular rosacea, compared with normal subjects.
  2. Dr. Richard Gallo, and Dr. Kenshi Yamasaki will continue their NRS-funded research of how cathelicidins, one of the body’s own natural antibiotics, may play a role in the development of rosacea symptoms.
  3. Dr. Richard Granstein will continue research on the role of adenosine triphosphate (ATP), an agent produced by nerves that earlier NRS-funded studies had shown initiates an inflammatory response in human dermal endothelial cells.
  4. Dr. Kent T. Keyser, will study the effects of nicotine on rosacea, to investigate which intracellular signaling pathways are affected and which cellular mechanisms may cause a reaction in rosacea.
  5. Dr. Martin Steinhoff will study the role of neuroimmune interactions in the pathophysiology of rosacea.

Previous National Rosacea Society News:

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.